Legal and financial questions of Pfizer-Novo-Metsera
Shareholder Primacy
00:00
How the FTC Intervened During the Shutdown
Mike explains the FTC's warning that the two‑part deal could be illegal and how that prompted MetSera and Novo to relent.
Play episode from 30:27
Transcript
